Bandaram Pharma Packtech Ltd

Bandaram Pharma Packtech Limited informed the BSE Limited that Cameo Corporate Services Limited, acting as the company’s RTA, has issued a certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018, for the quarter ended September 30, 2026.

Bandaram Pharma Packtech Limited will hold a board meeting on September 30, 2026, to consider a proposal for a scheme of arrangement/amalgamation, according to a regulatory filing with the BSE Limited. Trading window for the company’s securities will be closed for connected persons, officers, designated employees, insiders, directors, and their immediate relatives from September 27, 2026, and will remain closed until 48 hours after the declaration of the board meeting’s outcome.

Bandaram Pharma Packtech Limited (Scrip Code: 524602) will close its trading window from October 1, 2026, until 48 hours after the declaration of standalone and consolidated unaudited financial results for the quarter and half-year ended September 30, 2026, for designated persons, their immediate relatives, and connected persons, as per SEBI (Prohibition of Insider Trading) Regulations, 2015; the company will schedule a board meeting to consider and approve the results, and a separate notice will be sent to the BSE Limited.

Bandaram Pharma Packtech Ltd share price slipped 1.42% to Rs 18.69 after the company's net profit surged by 655.56% to Rs 0.68 crore, while revenue from operations eased by 8.80% to Rs 23.95 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Service Provider industry group stocks on BSE stood at Rs 73454.32 crore, rising 9.56%. It has inched up 2.51% over last one week and surged by 15.08% in last one month while the market capitalization of Bandaram Pharma Packtech Ltd has softened by 4.19% and 33.63% in the same period respectively. Profit before tax (PBT) of Bandaram Pharma Packtech Ltd stood at Rs 0.92 crore in Q2 FY26, jumping 2200.00% year-on-year, and expanding by 666.67% quarter-on-quarter. EBITDA came in at Rs 2 crore, rallying 144.44% YoY and surging by 90.12% sequentially. Total expenses contracted by 11.99% to Rs 22.61 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 21.61 crore, slightly declining by 8.55% YoY, while employee benefits expense was at Rs 0.73 crore, tanking by 67.56% YoY. For the TTM ended FY26, revenue from operations posted a slight growth of 8.45% to Rs 36.96 crore, while net profit saw a marginal increase of 4.21% to Rs 0.99 crore, compared to previous TTM. EBITDA jumped by 205% to Rs 2.73 crore, and PBT improved 10.92% to Rs 1.32 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 4.93 crore in FY26, as against Rs 4.13 crore in FY25. Bandaram Pharma Packtech Ltd tumbled by 50.65% in last one year, underperforming the benchmark BSE Sensex which has eased by 2.83% during the same period.

Bandaram Pharma Packtech Limited will hold a board meeting on August 13, 2026, to consider un-audited standalone and consolidated financial results for the quarter ended June 30, 2026, according to a regulatory filing with the BSE Limited. Trading in the company's securities, scrip code 524602, has been closed since July 1, 2026, and will remain so until 48 hours after the financial results are released, for connected persons, officers, designated employees, insiders, directors, and their immediate relatives.

Net profit of Bandaram Pharma Packtech declined 40.00% to Rs 0.09 crore in the quarter ended March 2026 as against Rs 0.15 crore during the previous quarter ended March 2025. Sales rose 209.31% to Rs 26.26 crore in the quarter ended March 2026 as against Rs 8.49 crore during the previous quarter ended March 2025. For the full year,net profit declined 18.18% to Rs 0.45 crore in the year ended March 2026 as against Rs 0.55 crore during the previous year ended March 2025. Sales rose 70.24% to Rs 62.92 crore in the year ended March 2026 as against Rs 36.96 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales26.268.49 209 62.9236.96 70 OPM %3.086.36 -4.617.66 - PBDT0.370.73 -49 1.412.30 -39 PBT0.120.20 -40 0.441.32 -67 NP0.090.15 -40 0.450.55 -18 Powered by Capital Market - Live

Bandaram Pharma Packtech will hold a meeting of the Board of Directors of the Company on 30 May 2026.

Bandaram Pharma Packtech announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 27 April 2026.

Net profit of Bandaram Pharma Packtech reported to Rs 0.19 crore in the quarter ended December 2025 as against net loss of Rs 0.01 crore during the previous quarter ended December 2024. Sales rose 48.40% to Rs 14.84 crore in the quarter ended December 2025 as against Rs 10.00 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales14.8410.00 48 OPM %6.746.60 - PBDT0.670.42 60 PBT0.530.27 96 NP0.19-0.01 LP Powered by Capital Market - Live

Bandaram Pharma Packtech will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live